scholarly journals Management of Ulcerative Colitis Using Vedolizumab After Liver Transplantation for Primary Sclerosing Cholangitis

2015 ◽  
Vol 10 (2) ◽  
pp. 236-236 ◽  
Author(s):  
Magdalena Meszaros ◽  
Georges-Philippe Pageaux ◽  
Romain Altwegg
2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Yinka K. Davies ◽  
Cynthia J. Tsay ◽  
Dario V. Caccamo ◽  
Kathleen M. Cox ◽  
Ricardo O. Castillo ◽  
...  

Primary sclerosing cholangitis (PSC) is a progressive, cholestatic disease of the liver that is marked by inflammation of the bile ducts and damage to the hepatic biliary tree. Approximately 60–70% of patients also have inflammatory bowel disease and progression of PSC can lead to ulcerative colitis and cirrhosis of the liver. Due to limited understanding of the etiology and mechanism of PSC, the only existing treatment option is orthotopic liver transplantation (OLT); however, recurrence of PSC, after OLT is estimated to be between 5% and 35%. We discuss the successful treatment of a pediatric patient, with recurrent PSC, after OLT with oral Vancomycin.


2007 ◽  
Vol 13 (4) ◽  
pp. 552-557 ◽  
Author(s):  
Evangelos Cholongitas ◽  
George V. Papatheodoridis ◽  
Paola Zappoli ◽  
Athanasios Giannakopoulos ◽  
David Patch ◽  
...  

2012 ◽  
Vol 10 (5) ◽  
pp. 540-546 ◽  
Author(s):  
Udayakumar Navaneethan ◽  
Preethi G.K. Venkatesh ◽  
Saurabh Mukewar ◽  
Bret A. Lashner ◽  
Feza H. Remzi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document